TrialThe Lancet. Infectious diseases2026

Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.

Thomas Louie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.